Speaker

Our main interest is the Hippo signalling pathway, a conserved growth-regulatory network that is dysregulated in many cancer types. In particular, we want to understand how Hippo signalling is coupled to both tissue architecture and systemic cues such as nutrient availability. We use a large array of methods, from Drosophila and mouse genetics, live imaging, through to proteomics, functional genomics and mathematical modelling.